| Host and Pathogen Factors for Clostridium difficile Infection and Colonization VG Loo, AM Bourgault, L Poirier, F Lamothe, S Michaud, N Turgeon, ... New England Journal of Medicine 365 (18), 1693-1703, 2011 | 970 | 2011 |
| Human metapneumovirus infections in hospitalized children G Boivin, G De Serres, S Côté, R Gilca, Y Abed, L Rochette, MG Bergeron, ... Emerging infectious diseases 9 (6), 634, 2003 | 561 | 2003 |
| Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring–summer 2009: four observational studies from Canada DM Skowronski, G De Serres, NS Crowcroft, NZ Janjua, N Boulianne, ... PLoS medicine 7 (4), e1000258, 2010 | 347 | 2010 |
| Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: a quasi-experimental controlled study Y Longtin, B Paquet-Bolduc, R Gilca, C Garenc, E Fortin, J Longtin, ... JAMA internal medicine 176 (6), 796-804, 2016 | 228 | 2016 |
| Human bocavirus infections in hospitalized children and adults J Longtin, M Bastien, R Gilca, E Leblanc, G De Serres, MG Bergeron, ... Emerging infectious diseases 14 (2), 217, 2008 | 209 | 2008 |
| Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease ME Hamelin, S Côtù, J Laforge, N Lampron, J Bourbeau, K Weiss, R Gilca, ... Clinical infectious diseases 41 (4), 498-502, 2005 | 155 | 2005 |
| Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons R Gilca, G De Serres, M Tremblay, ML Vachon, E Leblanc, MG Bergeron, ... The Journal of infectious diseases 193 (1), 54-58, 2006 | 135 | 2006 |
| Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada R Gilca, G De Serres, N Boulianne, N Ouhoummane, J Papenburg, ... Influenza and other respiratory viruses 5 (4), 247-255, 2011 | 123 | 2011 |
| Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada DM Skowronski, S Setayeshgar, Y Febriani, M Ouakki, M Zou, D Talbot, ... MedRxiv, 2021.10. 26.21265397, 2021 | 120 | 2021 |
| Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without … S Carazo, DM Skowronski, M Brisson, S Barkati, C Sauvageau, ... The Lancet Infectious Diseases 23 (1), 45-55, 2023 | 93 | 2023 |
| Impact of an immunization campaign to control an increased incidence of serogroup B meningococcal disease in one region of Quebec, Canada P De Wals, G Deceuninck, B Lefebvre, R Tsang, D Law, G De Serres, ... Clinical infectious diseases 64 (9), 1263-1267, 2017 | 85 | 2017 |
| Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing LY Kong, DW Eyre, J Corbeil, F Raymond, AS Walker, MH Wilcox, ... Clinical Infectious Diseases 68 (2), 204-209, 2019 | 75 | 2019 |
| Epidemiological patterns and hospital characteristics associated with increased incidence of Clostridium difficile infection in Quebec, Canada, 1998–2006 R Gilca, B Hubert, E Fortin, C Gaulin, M Dionne Infection Control & Hospital Epidemiology 31 (9), 939-947, 2010 | 72 | 2010 |
| Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time … R Gilca, É Fortin, C Frenette, Y Longtin, M Gourdeau Antimicrobial agents and chemotherapy 56 (2), 639-646, 2012 | 71 | 2012 |
| Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season R Gilca, R Amini, M Douville-Fradet, H Charest, J Dubuque, N Boulianne, ... Open forum infectious diseases 1 (2), ofu086, 2014 | 62 | 2014 |
| Infections by human coronavirus-NL in hospitalized children G Boivin, M Baz, S Côté, R Gilca, C Deffrasnes, É Leblanc, MG Bergeron, ... The Pediatric infectious disease journal 24 (12), 1045-1048, 2005 | 57 | 2005 |
| The need for validation of statistical methods for estimating respiratory virus–attributable hospitalization R Gilca, G De Serres, D Skowronski, G Boivin, DL Buckeridge American Journal of Epidemiology 170 (7), 925-936, 2009 | 53 | 2009 |
| Predictors of asymptomatic Clostridium difficile colonization on hospital admission LY Kong, N Dendukuri, I Schiller, AM Bourgault, P Brassard, L Poirier, ... American journal of infection control 43 (3), 248-253, 2015 | 52 | 2015 |
| A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following … R Gylca, V Gylca, O Benes, A Melnic, V Chicu, C Weisbecker, P Willems, ... Vaccine 19 (7-8), 825-833, 2000 | 51 | 2000 |
| Antibody persistence and response to 2010–2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children V Gilca, G De Serres, ME Hamelin, G Boivin, M Ouakki, N Boulianne, ... Vaccine 30 (1), 35-41, 2011 | 50 | 2011 |
